CIK 0000744218
- Large accelerated filer
Celldex Therapeutics, Inc.
Sign in to watch- Ticker
- CLDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133191702
- Phone
- +1 908-200-7500
- Business address
- 53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
- Former names
- AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-25 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Grant or award · Incentive Stock Option (right to buy) | +93,000 | 93,000 | ||
| 2025-12-04 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Sale | −4,166 | $29.10 | $121K | 30,796 |
| 2025-08-13 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Sale | −341 | $23.95 | $8K | 35,392 |
| 2025-08-13 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Sale | −430 | $25.42 | $11K | 34,962 |
| 2025-06-05 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Grant or award · Incentive Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2024-06-13 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Grant or award · Incentive Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2024-06-05 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Exercise or conversion | +9,540 | $10.38 | $99K | 35,464 |
| 2024-06-05 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Exercise or conversion · Incentive Stock Option (Right to Buy) | −9,540 | 18,454 | ||
| 2024-06-03 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Exercise or conversion | +8,006 | $10.38 | $83K | 33,930 |
| 2024-06-03 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Sale | −8,006 | $33.60 | $269K | 25,924 |
| 2024-06-03 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Exercise or conversion · Incentive Stock Option (Right to Buy) | −8,006 | 27,994 | ||
| 2024-02-13 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Exercise or conversion | +4,166 | $9.02 | $38K | 5,924 |
| 2024-02-13 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Exercise or conversion | +20,000 | $2.78 | $56K | 25,924 |
| 2024-02-13 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Exercise or conversion · Incentive Stock Option (Right to Buy) | −4,166 | 0 | ||
| 2024-02-13 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Exercise or conversion · Incentive Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2023-06-15 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Grant or award · Incentive Stock Option (right to buy) | +74,000 | 74,000 | ||
| 2022-06-16 | Jimenez Freddy A. SVP & GENERAL COUNSEL | Grant or award · Incentive Stock Option (right to buy) | +73,000 | 73,000 | ||
| 2021-08-11 | Jimenez Freddy A. SVP & General Counsel | Purchase | +430 | $46.28 | $20K | 430 |
| 2021-06-17 | Jimenez Freddy A. SVP & General Counsel | Grant or award · Incentive Stock Option (right to buy) | +73,000 | 73,000 |
Page 1 of 1 · 19 trades